Clinical Trials Sponsored by Derald H. Ruttenberg Cancer Center

Total 793 results

Memorial Sloan Kettering Cancer Center
Icahn School of Medicine at Mount Sinai; Hackensack Meridian Health; Derald H...

Completed

Behavioral Intervention For BMT/SCT Survivors (BMT/SCT)

Leukemia | Multiple Myeloma | Non-Hodgkin's Lymphoma | Hodgkin's Disease

United States
Robert H. Lurie Cancer Center
National Cancer Institute (NCI)

Withdrawn

Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer

Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer

United States
Northwestern University
Robert H. Lurie Cancer Center

Completed

Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery

Duct Cell Adenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer

United States
Northwestern University
Robert H. Lurie Cancer Center

Completed

Trial of VELCADE and Rituxan as Front-line Tx for Low-grade NHL

Non-Hodgkin's Lymphoma

United States
Northwestern University
Robert H. Lurie Cancer Center

Terminated

Effect of Weight Loss on Breast Density Using Digital Mammography and MRI in Women Who Are At Increased Risk For Breast Cancer

Healthy, no Evidence of Disease

United States
Northwestern University
Robert H. Lurie Cancer Center

Terminated

Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer

Metastatic Breast Cancer | Metastatic Non Small Cell Lung Cancer

United States
Northwestern University
Robert H. Lurie Cancer Center

Terminated

Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL

Non-Hodgkin's Lymphoma (NHL)

United States
Northwestern University
Robert H. Lurie Cancer Center

Completed

Dignity Therapy in mCRC to Increase Peaceful Awareness & Impact Goals of Care Decision-Making

Stage IV Colorectal Cancer

United States
Northwestern University
Robert H. Lurie Cancer Center

Withdrawn

Low Level Laser Therapy for Hair Preservation With Chemotherapy for Breast Cancer

Breast Cancer
Robert H. Lurie Cancer Center
National Cancer Institute (NCI)

Unknown

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
Robert H. Lurie Cancer Center
National Cancer Institute (NCI)

Unknown

Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus

Gastric Cancer | Esophageal Cancer

United States
Robert H. Lurie Cancer Center
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer

Head and Neck Cancer

United States
Northwestern University
Robert H. Lurie Cancer Center

Terminated

A Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHD

Bronchiolitis Obliterans

United States
Northwestern University
Robert H. Lurie Cancer Center

Completed

Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer | Adenocarcinoma of the Lung

United States
Northwestern University
Robert H. Lurie Cancer Center

Terminated

Phase I/II Trial of VELCADE Plus Zevalin in Patients With Relapsed or Refractory Follicular Lymphoma

Lymphoma

United States
Northwestern University
Robert H. Lurie Cancer Center

Terminated

Phase I/II Trial of Sodium Stibogluconate in Myelodysplastic Syndrome

Myelodysplastic Syndromes

United States
AC Camargo Cancer Center
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression (HORMONET)

Neuroendocrine Tumors | Estrogen Receptor Positive Tumor | Progesterone Receptor Positive Tumor

United States, Brazil
Hernia Center Rottenburg

Completed

Effectivity of Laparoscopic Inguinal Hernia Repair (TAPP) in Daily Clinical Practice - Early and Long-term Results

Unilateral Inguinal Hernia With Gangrene and Obstruction

Germany
Leo W. Jenkins Cancer Center
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Direct Tumor Injection KLH-Pulsed Dendritic Cells in Unresectable Pancreatic Cancer

Metastatic Pancreatic Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)

Rectal Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Study of CG0070 After Transurethral Resection in Patients With IR NMIBC

Non-muscle Invasive Bladder Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

REFLECT: Reproductive Education and Fertility Links for Cancer Treatment (REFLECT)

Reproductive Behavior

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Pilot Trial of Adaptive Radiotherapy Boost for HNSCC

Head and Neck Cancer | Squamous Cell Carcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Enhancing Cancer Survivorship With Pickleball

Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization

Benign Prostatic Hyperplasia | Prostate Carcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Barriers to Screening Breast MRI Utilization Among Patients at Elevated Risk (B-SUPER)

Breast Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer

Prostate Cancer | Advanced Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Phase I/II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell Lung Cancer

Non Small Cell Lung Cancer | Non Small Cell Lung Cancer Metastatic | Lung Cancer, Nonsmall Cell

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer Patients

Depressive Disorder | Depression | Cancer | Generalized Anxiety Disorder | Anxiety | Major Depressive Disorder

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic Melanoma

Metastatic Melanoma

United States
H. Lee Moffitt Cancer Center and Research Institute

Active, not recruiting

Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC

Lung Cancer | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Stage IV Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage IIIB | EGFR Negative Non-Small Cell Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors

Renal Cell Carcinoma | Non-Small Cell Lung Cancer | NSCLC | Solid Tumor | Metastatic Cancer | Squamous Cell Carcinoma of the Head and Neck | Urothelial Carcinoma | Squamous Cell Carcinoma | Recurrent Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Mobile APP Utilization for Enhanced Post-Operative Nutritional Recovery

GI Cancer | Nutritional Deficiency

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE

Hepatocellular Carcinoma | Liver Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

CARES-HCV: Promoting Screening Uptake Among Diverse Baby Boomers

Hepatitis C Virus Infection | Colorectal Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Hypofractionated Stereotactic Irradiation With Nivolumab, Ipilimumab and Bevacizumab in Patients With Recurrent High Grade Gliomas

Malignant Glioma

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer

Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Health Beliefs, Behaviors, and Healthcare Experiences Among United States Young and Mid-Age Adults

HPV Vaccine Knowledge

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Study of T-VEC in Locally Advanced Cutaneous Angiosarcoma

Angiosarcoma of Skin

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Capecitabine and Lenvatinib With External Radiation in Rectal Adenocarcinoma

Rectal Cancer | Rectal Adenocarcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas

Pancreatic Cancer | Gastro-enteropancreatic Neuroendocrine Tumor | Neuroendocrine Carcinomas of Pancreas | Islet Cell Carcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Randomized Controlled Trial of Endoscopic Dilation: Triamcinolone Injection

Dysphagia

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

In Vivo Treg Expansion and Graft-Versus-Host Disease Prophylaxis

Graft-Versus-Host-Disease

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Feasibility Study of Ultrasound Elastography Detecting Prostate Cancer

Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)

Lymphoma | Myelodysplastic Syndromes | Myeloproliferative Disorders | Myeloma | Leukemia, Lymphocytic

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Exploration of Immune Response to Early PCV13 Vaccination in Conjunction With Autologous Transplant (PCV13)

Multiple Myeloma

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus

Gastric Cancer | Esophageal Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Bicarbonate for Tumor Related Pain

Neoplasm Related Pain (Acute) (Chronic)

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Pilot Study to Validate Metallic Markers for Image Guided Radiation Therapy for Breast Cancer Tx

Breast Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Biomarker Driven Patient Selection Neoadjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma

Melanoma | Advanced Melanoma | Melanoma Stage IV | Melanoma Stage III

United States

Clinical Trials Sponsored by Derald H. Ruttenberg Cancer Center

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations